Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 20, 2016HepatologyOpen Access

The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe

View Full Paper
Ask AI
Bookmark
Share

Authors

ZYZobair M. YounossiDBDeirdre B BlissettRBRobert Blissett

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Younossi et al. (2016) studied this question.

synapsesocial.com/papers/69dd5cbe629747396240c409https://doi.org/10.1002/hep.28785
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Health-related quality of life in chronic liver disease: the impact of type and severity of disease2001 · 322 citations
  2. 2The cost-effectiveness of daclatasvir-based regimens for the treatment of hepatitis C virus genotypes 1 and 4 in the UK2015 · 19 citations
  3. 3Reliability and validity of the Chronic Liver Disease Questionnaire (CLDQ) in adults with non-alcoholic steatohepatitis (NASH)2016 · 65 citations
  4. 4Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality2016 · 336 citations